Human mast cell and tissue acquisition core
人类肥大细胞和组织采集核心
基本信息
- 批准号:10331724
- 负责人:
- 金额:$ 12.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-06 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Allergic DiseaseAtopic DermatitisBiopsyBiopsy SpecimenBone MarrowBone Marrow TransplantationCD34 geneCatalogsCell LineCell TransplantationCellsChildhoodCollaborationsEndoscopic BiopsyEnsureEosinophilic Gastrointestinal DiseaseExcisionGenerationsGoalsGranulocyte-Macrophage Colony-Stimulating FactorHospitalsHumanIL3 GeneIn VitroLarge IntestineLeadershipLettersLigandsLungMethodsMucous MembraneMusNasal PolypsOperative Surgical ProceduresPathologyPatientsPhysiciansSamplingScientistServicesShipsSinusSkinSourceSpecimenStandardizationSupervisionTechniquesTissuesTransgenic MiceTransgenic OrganismsUniversitiesbone cellchronic rhinosinusitiscohortcytokineexperienceexperimental studyhuman tissuemast cellmedical schoolssialic acid binding Ig-like lectinsuccess
项目摘要
ABSTRACT
The goals of the human mast cell and tissue acquisition Core B are focused and straightforward: to provide
key services that will be used by all three Projects. Core B will provide well-defined materials to each of these
projects to ensure coordinated methods of approach, and will be available to troubleshoot if problems arise.
Located at the Northwestern University Feinberg School of Medicine under the leadership and supervision of
Dr. Bruce Bochner, Core B will procure, catalog, store and ship de-identified biopsy samples from subjects with
chronic rhinosinusitis, eosinophilic gastrointestinal disorders and atopic dermatitis in collaboration with
physicians and scientists located at Northwestern for use primarily by Project 3. A second important task for
Core B is to generate enriched mature human mast cells derived from tissues such as discarded human skin,
as well as samples of human large intestine and lung resection specimens from the Northwestern Memorial
Hospital for use in in vitro experiments. The third focus of Core B is to assist with and directly generate
“humanized” mast cell mice employing a method by which CD34+ human cells are transplanted into the triple
transgenic NSG-SGM3 (NSGS) mice expressing human IL-3, GM-CSF and SCF. Finally, the fourth
responsibility of Core B is to maintain important human and mouse mast cell lines, and to generate culture-
derived mouse mast cells from bone marrow of mice expressing human Siglecs and from the bone marrow of
the transplanted NSGS mice to generate culture-derived human mast cells, the latter two for use primarily by
Projects 1 and 2. In short, Core B will provide an efficient, standardized and centralized source for mast cells,
humanized mast cell mice, and human tissue specimens. The experience and expertise in isolating and
generating mast cells will be critical to the success of Project 1 and Project 2, while the availability of de-
identified biopsies and discarded surgical tissues from well-characterized cohorts of patients and controls are
essential to the aims of Project 3.
摘要
人类肥大细胞和组织采集核心B的目标是集中和直接的:提供
这三个项目将使用的关键服务。核心B将为每个核心提供定义明确的材料,
项目,以确保协调方法的做法,并将提供故障排除,如果出现问题。
位于西北大学范伯格医学院的领导和监督下,
博士布鲁斯博克纳,核心B将从受试者中采购、分类、储存和运输去识别的活检样本,
慢性鼻窦炎、嗜酸性胃肠疾病和特应性皮炎,
西北大学的医生和科学家主要由项目3使用。第二项重要任务是
核心B是从组织如废弃的人皮肤产生富集的成熟人肥大细胞,
以及来自西北纪念馆的人类大肠和肺切除标本样本
医院用于体外实验。核心B的第三个重点是协助和直接生成
使用将CD 34+人细胞移植到三重细胞中的方法的“人源化”肥大细胞小鼠。
表达人IL-3、GM-CSF和SCF的转基因NSG-SGM 3(NSGS)小鼠。最后,第四个
核心B的职责是维持重要的人类和小鼠肥大细胞系,并产生培养物-
从表达人Siglec的小鼠的骨髓和从表达人Siglec的小鼠的骨髓衍生的小鼠肥大细胞
移植的NSGS小鼠产生培养衍生的人肥大细胞,后两者主要用于
项目1和2。简而言之,核心B将为肥大细胞提供高效、标准化和集中的来源,
人源化肥大细胞小鼠和人组织样本。在分离和
产生肥大细胞对项目1和项目2的成功至关重要,而去-
从充分表征的患者和对照组中鉴定的活检和丢弃的手术组织,
对项目3的目标至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce S Bochner其他文献
Bruce S Bochner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce S Bochner', 18)}}的其他基金
Exploiting Siglec-6 for targeted anti-allergy drug delivery into human mast cells
利用 Siglec-6 将靶向抗过敏药物输送到人体肥大细胞中
- 批准号:
10368109 - 财政年份:2021
- 资助金额:
$ 12.29万 - 项目类别:
Exploiting Siglec-6 for targeted anti-allergy drug delivery into human mast cells
利用 Siglec-6 将靶向抗过敏药物输送到人体肥大细胞中
- 批准号:
10194041 - 财政年份:2021
- 资助金额:
$ 12.29万 - 项目类别:
Using siglecs and their ligands to treat allergic diseases SALTAD
使用siglecs及其配体治疗过敏性疾病SALTAD
- 批准号:
10331722 - 财政年份:2018
- 资助金额:
$ 12.29万 - 项目类别:
Defining Siglec-6 and Siglec-8 function on effector cells of allergic diseases
定义 Siglec-6 和 Siglec-8 对过敏性疾病效应细胞的功能
- 批准号:
10097994 - 财政年份:2018
- 资助金额:
$ 12.29万 - 项目类别:
Using siglecs and their ligands to treat allergic diseases SALTAD
使用siglecs及其配体治疗过敏性疾病SALTAD
- 批准号:
10097976 - 财政年份:2018
- 资助金额:
$ 12.29万 - 项目类别:
Defining Siglec-6 and Siglec-8 function on effector cells of allergic diseases
定义 Siglec-6 和 Siglec-8 对过敏性疾病效应细胞的功能
- 批准号:
10331725 - 财政年份:2018
- 资助金额:
$ 12.29万 - 项目类别:
Northwestern University Allergy and Immunology Research (NUAIR) Program
西北大学过敏与免疫学研究 (NUAIR) 项目
- 批准号:
10207416 - 财政年份:2010
- 资助金额:
$ 12.29万 - 项目类别:
相似海外基金
Elucidation of atopic dermatitis pathology through nucleic acid-independent single-cell microbiome analysis
通过不依赖核酸的单细胞微生物组分析阐明特应性皮炎病理学
- 批准号:
23H02930 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanism related to dental metal allergy to exacerbation of atopic dermatitis
阐明牙科金属过敏与特应性皮炎恶化的相关机制
- 批准号:
23K16062 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis
拉丁裔特应性皮炎患者丝聚蛋白基因突变的调查
- 批准号:
10740811 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Genetic analysis of the pathogenesis of atopic dermatitis focusing on the allergic sensitivity of NC mice.
以NC小鼠过敏敏感性为重点的特应性皮炎发病机制的遗传分析。
- 批准号:
23K05600 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of the pathogenic mechanism of atopic dermatitis-associated brain inflammation
阐明特应性皮炎相关脑炎症的发病机制
- 批准号:
23KF0068 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
- 批准号:
485092 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Operating Grants
Patient engagement in atopic dermatitis (eczema) guidelines and a model for future trustworthy, patient-centred guidelines
患者参与特应性皮炎(湿疹)指南以及未来值得信赖、以患者为中心的指南模型
- 批准号:
485111 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Operating Grants
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
- 批准号:
485106 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别:
Operating Grants
Defining the role of IL-18 in atopic dermatitis
定义 IL-18 在特应性皮炎中的作用
- 批准号:
10681016 - 财政年份:2023
- 资助金额:
$ 12.29万 - 项目类别: